Precision measurement company Mettler-Toledo (NYSE: MTD) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.5% year on year to $1.03 billion. Its non-GAAP profit of $11.46 per share was 6.1% above analysts’ consensus estimates.

Is now the time to buy Mettler-Toledo? Find out by accessing our full research report, it’s free.

Company Overview

With roots dating back to the precision balance innovations of Swiss engineer Erhard Mettler, Mettler-Toledo (NYSE: MTD) manufactures precision weighing instruments, analytical equipment, and product inspection systems used in laboratories, industrial settings, and food retail.

Revenue Growth

A company’s long-term sales performance can indicate its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last five years, Mettler-Toledo grew its sales at a tepid 3.5% compounded annual growth rate. This was below our standard for the healthcare sector and is a tough starting point for our analysis.

We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. Mettler-Toledo’s annualized revenue growth of 5% over the last two years is above its five-year trend, which is encouraging.

We can better understand the company’s sales dynamics by analyzing its organic revenue, which strips out one-time events like acquisitions and currency fluctuations that don’t accurately reflect its fundamentals. Over the last two years, Mettler-Toledo’s organic revenue averaged 3.7% year-on-year growth. Because this number aligns with its two-year revenue growth, we can see the company’s core operations (not acquisitions and divestitures) drove most of its results.

This quarter, Mettler-Toledo grew its revenue by 4.5% year on year, and its $1.03 billion of revenue was in line with Wall Street’s estimates.

Looking ahead, sell-side analysts expect revenue to grow 4.7% over the next 12 months, similar to its two-year rate. This projection doesn’t excite us and indicates its newer products and services will not catalyze better top-line performance yet.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Operating Margin

Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses — everything from the cost of goods sold to advertising and wages. It’s also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes.

Mettler-Toledo’s operating margin has generally stayed the same over the last 12 months, averaging 28.2% over the last five years. This profitability was top-notch for a healthcare business, showing it’s a well-run company with an efficient cost structure.

Analyzing the trend in its profitability, Mettler-Toledo’s operating margin might have fluctuated slightly but has generally stayed the same over the last five years. This raises questions about the company’s expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability.

in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth — for example, a company could inflate its sales through excessive spending on advertising and promotions.

Mettler-Toledo’s EPS grew at 7.7% compounded annual growth rate over the last five years, higher than its 3.5% annualized revenue growth. However, this alone doesn’t tell us much about its business quality because its operating margin didn’t improve.

We can take a deeper look into Mettler-Toledo’s earnings to better understand the drivers of its performance. A five-year view shows that Mettler-Toledo has repurchased its stock, shrinking its share count by 14.3%. This tells us its EPS outperformed its revenue not because of increased operational efficiency but financial engineering, as buybacks boost per share earnings.

In Q2, Mettler-Toledo reported adjusted EPS of $11.46, up from $10.09 in the same quarter last year. This print beat analysts’ estimates by 6.1%. Over the next 12 months, Wall Street expects Mettler-Toledo’s full-year EPS to grow 9.2% from $44.88 to $48.99.

Key Takeaways from Mettler-Toledo’s Q2 Results

We enjoyed seeing Mettler-Toledo beat analysts’ organic revenue expectations this quarter. We were also happy its full-year EPS guidance narrowly outperformed Wall Street’s estimates. On the other hand, its revenue was in line. Overall, this print had some key positives. The stock traded up 2.3% to $1,413 immediately following the results.

Mettler-Toledo put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).